Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9357-9366

  Tang, S ^a   Murakami, T ^a   Agresta, B E ^a   Campbell, S ^a   Freed, E O ^a   Levin, J G ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE;

AMINO TERMINAL SEQUENCE; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRION; VIRUS CAPSID; VIRUS CORE; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS PARTICLE;

GENE PRODUCTS, GAG; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0034855639     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9357-9366.2001     Document Type: Article

References (61)

1. gag
2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
3. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection
4. Second-site suppressors of Rous sarcoma virus CA mutations: Evidence for interdomain interactions
5. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription
6. Integration
7. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants
8. Functional domains of the capsid protein of human immunodeficiency virus type 1
9. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro
10. 2-terminal capsid domain: Structure determinants for proper core assembly and subsequent steps of early replication
11. Specific incorporation of cyclophilin A into HIV-1 virions
12. HIV-1 Gag proteins: Diverse functions in the virus life cycle
13. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity
14. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection
15. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120
16. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
17. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions
18. Maturation of dimeric viral RNA of Moloney murine leukemia virus
19. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid
20. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
21. Assembly and analysis of conical models for the HIV-1 core
22. Assembly and morphology of HIV: Potential effect of structure on viral function
23. Structure of the amino-terminal core domain of the HIV-1 capsid protein
24. Role of Vif in human immunodeficiency virus type 1 reverse transcription
25. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles
26. A conformational switch controlling HIV-1 morphogenesis
27. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA
28. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processings, and complete amino acid sequences
29. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
30. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle
31. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity
32. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
33. Generation of HIV-1/HIV-2 cross-reactive peptide antisera by small sequence changes in HIV-1 reverse transcriptase and integrase immunizing peptides
34. Association of Nef with the human immunodeficiency virus type 1 core
35. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
36. Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range
37. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in ceils treated with actinomycin D
38. Viral DNA carried by human immunodeficiency virus type 1 virions
39. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors
40. Functional analysis of reverse transcription by a frame-shift pol mutant of murine leukemia virus
41. Crystal structure of dimeric HIV-1 capsid protein
42. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle
43. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: Effects on virion particle assembly, release, and infectivity
44. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication
45. In vitro synthesis of infectious DNA of murine leukaemia virus
46. Synthesis, assembly, and processing of viral proteins
47. Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5′ untranslated region (5′UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5′UTR sequence
48. Functional association of cyclophilin A with HIV-1 virions
49. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers
50. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses
51. Structural biology of HIV
52. Retroviral virions and genomes
53. Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy
54. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly
55. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants
56. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1
57. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid
58. Form, function, and use of retroviral Gag proteins
59. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex
60. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
61. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle